Alprazolam
3 mg · Tablet, Extended Release
- Prescription only
- Controlled substance · CIV
- Benzodiazepine
- Active substance
- Alprazolam
- Made by
- Aurobindo Pharma Limited
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
How it works
From the US prescribing label for the same active substance (Alprazolam). It describes the substance, not this exact product.
Alprazolam is a 1,4 benzodiazepine.
Alprazolam exerts its effect for the acute treatment of generalized anxiety disorder and panic disorder through binding to the benzodiazepine site of gamma-aminobutyric acid-A (GABA A ) receptors in the brain and enhances GABA-mediated synaptic inhibition.
Alprazolam is extensively metabolized in humans, primarily by cytochrome P450 3A4 (CYP3A4), to 2 major active metabolites in the plasma: 4-hydroxyalprazolam and α-hydroxyalprazolam.
Alprazolam and its metabolites are excreted primarily in the urine.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2026-07-28
Safety of the active substance
From the US prescribing label for the same active substance (Alprazolam). It describes the substance, not this exact product.
WARNING: RISKS FROM CONCOMITANT USE WITH OPIOIDS; ABUSE, MISUSE, AND ADDICTION; and DEPENDENCE AND WITHDRAWAL REACTIONS Concomitant use of benzodiazepines and opioids may result in profound sedation, respiratory depression, coma, and death.
- Alprazolam tablets are contraindicated in patients: with known hypersensitivity to alprazolam or other benzodiazepines.
- Angioedema has been reported [see Adverse Reactions (6.2) ]. taking strong cytochrome P450 3A (CYP3A) inhibitors (e.g., ketoconazole, itraconazole), except ritonavir [see Dosage and Administration (2.6), Warnings and Precautions (5.5), Drug Interactions (7.1) ] Known hypersensitivity to alprazolam or other benzodiazepines.
- ( 4 ) Concomitant use with strong cytochrome P450 3A (CYP3A) inhibitors, except ritonavir.
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
BulgariaNo exact match for this strength and form
Spain1 matching products
FranceNo exact match for this strength and form
CanadaNo exact match for this strength and form
NetherlandsNo exact match for this strength and form
Details
| Made by | Aurobindo Pharma Limited |
|---|---|
| Active substance | Alprazolam |
| Used in | Pain, sleep, mood, epilepsy and the brain |
| Strength | 3 mg |
| Form | Tablet, Extended Release |
| Route | Oral |
| Packs | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE · 7000 TABLET, EXTENDED RELEASE in 1 BOTTLE |
| NDC | 65862-457 |
Source: NDC Directory · 2026-09-13 · not reviewed by a clinician
Source: US Food and Drug Administration, NDC Directory. Reuse terms: US government work (FDA).
Other strengths and forms
104 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
- Tablet79 products
- Tablet, Extended Release16 products
2 mg3
2 mg · 3 companies
3 mg3
3 mg · 3 companies
- Amneal Pharmaceuticals LLC
- Asclemed USA, Inc.
- Aurobindo Pharma Limited · this page
- Tablet, Orally Disintegrating8 products
.25 mg2
.25 mg · 2 companies
.5 mg2
.5 mg · 2 companies
1 mg2
1 mg · 2 companies
2 mg2
2 mg · 2 companies
- Solution, Concentrate1 products
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.